iifl-logo

Suraksha Diagnostic Ltd Board Meeting

266.95
(2.99%)
Apr 1, 2025|12:00:00 AM

CORPORATE ACTIONS

02/04/2024calendar-icon
02/04/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting27 Mar 202527 Mar 2025
Information about acquisition
Board Meeting8 Feb 20253 Feb 2025
Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended 31 December 2024 1. The unaudited financial results (standalone and consolidated) of the Company for the quarter and nine months ended 31 December 2024 and the same is enclosed along with the Limited Review Report issued by the Statutory Auditors of the Company. 2. Appointment of Mr. Ravindra K S as the Chief Financial Officer with effect from 01 March 2025, who will also act as a Group Chief Financial Officer. 3. Amended Policies of the Company. (As Per Bse Announcement Dated on 08.02.2025)
Board Meeting20 Dec 202414 Dec 2024
Suraksha Diagnostic Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/12/2024 inter alia to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 20 December 2024 at the registered office of the Company inter-alia to consider approve and take on record the unaudited standalone and consolidated financial results of the Company for the quarter and six months ended 30 September 2024. 1.Unaudited Financial Results (Standalone and Consolidated) of the Company for quarter and six months ended 30 September 2024; 2. Postal Ballot Notice for seeking shareholders approval for the ratification of Suraksha Employee Stock Option Scheme 2024 (ESOP 2024/ Scheme)3. Formation of a Special Purpose Vehicle Company (SPV) (As per BSE Announcement Dated on 20/12/2024) Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 for incorporation of Suraksha Advanced Radiology Private Limited, Subsidiary of the Company. (As Per BSE Announcement dated on 22.01.2025)

Suraksha Diagnostic Ltd: Related News

Suraksha Diagnostics IPO Subscription Details on Day 2
2 Dec 2024|01:05 PM

Suraksha Diagnostics specializes in medical consultancy services, hoping to attract investors in the rising healthcare sector

Read More
Suraksha Diagnostic Sets ₹846 Crore IPO with Price Band of ₹420-441 per Share
27 Nov 2024|09:13 PM

The anchor book, available to institutional investors, will open a day earlier, on November 28, 2024.

Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.